MedPath

Comparison of the effect of violet plant vaginal gel and metronidazole tablet on treatment of trichomonas vaginalis

Phase 3
Conditions
trichomonas vaginalis.
Vaginitis, vulvitis and vulvovaginitis in diseases classified elsewhere
N77.1
Registration Number
IRCT20240529061938N1
Lead Sponsor
Ahvaz University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
Female
Target Recruitment
80
Inclusion Criteria

Married women 15-45 years old
Sexually active women
Having a complaint of discharge
Diagnosis of Trichomonas vaginalis by clinical examination and laboratory tests (wet slide).

Exclusion Criteria

pregnant women
Lactating women
It is possible to start menstruation in the next 10 days
Abnormal and unknown vaginal bleeding
Sexual intercourse in the last 48 hours
Use of vaginal drugs in the last 48 hours
Use of immunosuppressive drugs
Use of broad-spectrum antibiotics
Diagnosis of bacterial vaginitis or candida albicans in vaginal secretions

Study & Design

Study Type
observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath